Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Association of rare non-coding SNVs in the lung-specific FOXF1 enhancer with a mitigation of the lethal ACDMPV phenotype

P. Szafranski, Q. Liu, JA. Karolak, X. Song, N. de Leeuw, B. Faas, R. Gerychova, P. Janku, M. Jezova, I. Valaskova, KA. Gibbs, LF. Surrey, V. Poisson, D. Bérubé, LL. Oligny, JL. Michaud, E. Popek, P. Stankiewicz,

. 2019 ; 138 (11-12) : 1301-1311. [pub] 20191104

Jazyk angličtina Země Německo

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19044496

Grantová podpora
R01 HL137203 NHLBI NIH HHS - United States
R01HL137203 NHLBI NIH HHS - United States
16001 National Organization for Rare Disorders

E-zdroje NLK Online Plný text

ProQuest Central od 2000-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 2000-01-01 do Před 1 rokem

Haploinsufficiency of FOXF1 causes alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV), a lethal neonatal lung developmental disorder. We describe two similar heterozygous CNV deletions involving the FOXF1 enhancer and re-analyze FOXF1 missense mutation, all associated with an unexpectedly mitigated disease phenotype. In one case, the deletion of the maternal allele of the FOXF1 enhancer caused pulmonary hypertension and histopathologically diagnosed MPV without the typical ACD features. In the second case, the deletion of the paternal enhancer resulted in ACDMPV rather than the expected neonatal lethality. In both cases, FOXF1 expression in lung tissue was higher than usually seen or expected in patients with similar deletions, suggesting an increased activity of the remaining allele of the enhancer. Sequencing of these alleles revealed two rare SNVs, rs150502618-A and rs79301423-T, mapping to the partially overlapping binding sites for TFAP2s and CTCF in the core region of the enhancer. Moreover, in a family with three histopathologically-diagnosed ACDMPV siblings whose missense FOXF1 mutation was inherited from the healthy non-mosaic carrier mother, we have identified a rare SNV rs28571077-A within 2-kb of the above-mentioned non-coding SNVs in the FOXF1 enhancer in the mother, that was absent in the affected newborns and 13 unrelated ACDMPV patients with CNV deletions of this genomic region. Based on the low population frequencies of these three variants, their absence in ACDMPV patients, the results of reporter assay, RNAi and EMSA experiments, and in silico predictions, we propose that the described SNVs might have acted on FOXF1 enhancer as hypermorphs.

000      
00000naa a2200000 a 4500
001      
bmc19044496
003      
CZ-PrNML
005      
20200114085520.0
007      
ta
008      
200109s2019 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00439-019-02073-x $2 doi
035    __
$a (PubMed)31686214
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Szafranski, Przemyslaw $u Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
245    10
$a Association of rare non-coding SNVs in the lung-specific FOXF1 enhancer with a mitigation of the lethal ACDMPV phenotype / $c P. Szafranski, Q. Liu, JA. Karolak, X. Song, N. de Leeuw, B. Faas, R. Gerychova, P. Janku, M. Jezova, I. Valaskova, KA. Gibbs, LF. Surrey, V. Poisson, D. Bérubé, LL. Oligny, JL. Michaud, E. Popek, P. Stankiewicz,
520    9_
$a Haploinsufficiency of FOXF1 causes alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV), a lethal neonatal lung developmental disorder. We describe two similar heterozygous CNV deletions involving the FOXF1 enhancer and re-analyze FOXF1 missense mutation, all associated with an unexpectedly mitigated disease phenotype. In one case, the deletion of the maternal allele of the FOXF1 enhancer caused pulmonary hypertension and histopathologically diagnosed MPV without the typical ACD features. In the second case, the deletion of the paternal enhancer resulted in ACDMPV rather than the expected neonatal lethality. In both cases, FOXF1 expression in lung tissue was higher than usually seen or expected in patients with similar deletions, suggesting an increased activity of the remaining allele of the enhancer. Sequencing of these alleles revealed two rare SNVs, rs150502618-A and rs79301423-T, mapping to the partially overlapping binding sites for TFAP2s and CTCF in the core region of the enhancer. Moreover, in a family with three histopathologically-diagnosed ACDMPV siblings whose missense FOXF1 mutation was inherited from the healthy non-mosaic carrier mother, we have identified a rare SNV rs28571077-A within 2-kb of the above-mentioned non-coding SNVs in the FOXF1 enhancer in the mother, that was absent in the affected newborns and 13 unrelated ACDMPV patients with CNV deletions of this genomic region. Based on the low population frequencies of these three variants, their absence in ACDMPV patients, the results of reporter assay, RNAi and EMSA experiments, and in silico predictions, we propose that the described SNVs might have acted on FOXF1 enhancer as hypermorphs.
650    _2
$a dospělí $7 D000328
650    _2
$a dítě $7 D002648
650    12
$a zesilovače transkripce $7 D004742
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a forkhead transkripční faktory $x genetika $7 D051858
650    _2
$a genomový imprinting $7 D018392
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    12
$a missense mutace $7 D020125
650    _2
$a syndrom přetrvávajícího fetálního oběhu $x genetika $x patologie $x prevence a kontrola $7 D010547
650    _2
$a fenotyp $7 D010641
650    12
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a prognóza $7 D011379
650    12
$a sekvenční delece $7 D017384
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Liu, Qian $u Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
700    1_
$a Karolak, Justyna A $u Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Song, Xiaofei $u Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
700    1_
$a de Leeuw, Nicole $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
700    1_
$a Faas, Brigitte $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
700    1_
$a Gerychova, Romana $u Department of Obstetrics and Gynecology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
700    1_
$a Janku, Petr $u Department of Obstetrics and Gynecology, Masaryk University and University Hospital Brno, Brno, Czech Republic. Department of Nursing and Midwifery, Masaryk University, Brno, Czech Republic.
700    1_
$a Jezova, Marta $u Department of Pathology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
700    1_
$a Valaskova, Iveta $u Department of Medical Genetics, Masaryk University and University Hospital Brno, Brno, Czech Republic.
700    1_
$a Gibbs, Kathleen A $u Children's Hospital of Philadelphia, Philadelphia, PA, USA.
700    1_
$a Surrey, Lea F $u Children's Hospital of Philadelphia, Philadelphia, PA, USA. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA, USA.
700    1_
$a Poisson, Virginie $u CHU Sainte-Justine, Montreal, Québec, Canada. Department of Pediatrics, Université de Montréal, Montreal, Québec, Canada.
700    1_
$a Bérubé, Denis $u CHU Sainte-Justine, Montreal, Québec, Canada. Department of Pediatrics, Université de Montréal, Montreal, Québec, Canada.
700    1_
$a Oligny, Luc L $u CHU Sainte-Justine, Montreal, Québec, Canada. Department of Pathology, Université de Montréal, Montreal, Québec, Canada.
700    1_
$a Michaud, Jacques L $u CHU Sainte-Justine, Montreal, Québec, Canada. Department of Pediatrics, Université de Montréal, Montreal, Québec, Canada.
700    1_
$a Popek, Edwina $u Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
700    1_
$a Stankiewicz, Paweł $u Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. pawels@bcm.edu.
773    0_
$w MED00002074 $t Human genetics $x 1432-1203 $g Roč. 138, č. 11-12 (2019), s. 1301-1311
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31686214 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200114085852 $b ABA008
999    __
$a ok $b bmc $g 1482765 $s 1083169
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 138 $c 11-12 $d 1301-1311 $e 20191104 $i 1432-1203 $m Human genetics $n Hum. genet. $x MED00002074
GRA    __
$a R01 HL137203 $p NHLBI NIH HHS $2 United States
GRA    __
$a R01HL137203 $p NHLBI NIH HHS $2 United States
GRA    __
$a 16001 $p National Organization for Rare Disorders
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...